General
General
News Roundup: Takeda In Talks To Buy Cipla, Lupin
Takeda In Talks To Buy Cipla, Lupin - Takeda, Japan's largest pharmaceutical firm, has begun talks with two of India's ......
General
Barclays Capital India Appoints Bhuvnesh, Neel To Head Equity Biz
Barclays Capital India, the investment banking division of Barclays Bank Plc., has appointed Bhuvnesh Singh as head of equity research ......
General
Tata Capital Ropes In Capvent's Joe Sovran For PE Biz
Tata Capital, the financial services arm of the $83.6 billion Tata Group, has roped in Capvent’s Joe Sovran for its ......
General
Deven Sharma To Step Down As S&P President
Deven Sharma is stepping down as president of Standard & Poor’s only weeks after the rating agency issued an unprecedented ......
General
News Roundup: Sanofi In Advanced Talks To Buy Universal Medicare
Sanofi In Advanced Talks To Buy Universal Medicare - Sanofi-Aventis is in advanced talks for a strategic tie-up with nutraceuticals ......
General
The Upcoming Patent Cliff: Implications For Indian Pharma
The leading global pharmaceutical firms are facing some challenging times as a significant number of patents for branded drugs are ......
General
Google's Motorola Deal: From The Frying Pan Into The Fire
The business world was surprised when Google announced it was acquiring Motorola Mobility for $12.5 billion – 63 per cent ......
General
Heartbreak Hotel: The IP Laundry List For Start-ups
One of the more endearing aspects of my clients is their sheer belief. In the recent years, we have ......
General
Why A Bad CEO Is A Company Killer
"You've got to be kidding me," was the line tennis great John McEnroe made famous. He would yell it at ......
General
News Roundup: Nexus To Raise $250M For Third Venture Fund
Nexus To Raise $250M For Third Venture Fund - Nexus Venture Partners will be raising a $250 million fund, its ......
